Literature DB >> 25465042

The role of the spleen in ischemic stroke.

Keith R Pennypacker1, Halina Offner2.   

Abstract

This opinion piece highlights the scientific literature reporting that the peripheral immune response to ischemic stroke originates from the spleen. Removal of the spleen not only reduces stroke-induced neurodegeneration but also cellular degeneration in the body's other tissues when exposed to ischemic conditions.

Entities:  

Mesh:

Year:  2014        PMID: 25465042      PMCID: PMC4426754          DOI: 10.1038/jcbfm.2014.212

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  20 in total

Review 1.  Reactive oxygen and mechanisms of inflammatory liver injury.

Authors:  H Jaeschke
Journal:  J Gastroenterol Hepatol       Date:  2000-07       Impact factor: 4.029

2.  Role of spleen-derived monocytes/macrophages in acute ischemic brain injury.

Authors:  Eunhee Kim; Jiwon Yang; Cesar D Beltran; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-28       Impact factor: 6.200

Review 3.  Therapeutic approaches for ischemia/reperfusion injury in the liver.

Authors:  C Fan; R M Zwacka; J F Engelhardt
Journal:  J Mol Med (Berl)       Date:  1999-08       Impact factor: 4.599

4.  Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat.

Authors:  Y Okuaki; H Miyazaki; M Zeniya; T Ishikawa; Y Ohkawa; S Tsuno; M Sakaguchi; M Hara; H Takahashi; G Toda
Journal:  Liver       Date:  1996-06

5.  Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model.

Authors:  Robert P Ostrowski; Reinhard W Schulte; Ying Nie; Ted Ling; Timothy Lee; Anatol Manaenko; Daila S Gridley; John H Zhang
Journal:  Transl Stroke Res       Date:  2012-12       Impact factor: 6.829

6.  Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

Authors:  Halina Offner; Sandhya Subramanian; Susan M Parker; Chunhe Wang; Michael E Afentoulis; Anne Lewis; Arthur A Vandenbark; Patricia D Hurn
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

7.  Cord blood rescues stroke-induced changes in splenocyte phenotype and function.

Authors:  Martina Vendrame; Carmelina Gemma; Keith R Pennypacker; Paula C Bickford; Cyndy Davis Sanberg; Paul R Sanberg; Alison E Willing
Journal:  Exp Neurol       Date:  2006-05-19       Impact factor: 5.330

8.  The spleen contributes to stroke-induced neurodegeneration.

Authors:  Craig T Ajmo; Dionne O L Vernon; Lisa Collier; Aaron A Hall; Svitlana Garbuzova-Davis; Alison Willing; Keith R Pennypacker
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

9.  Splenectomy protects experimental rats from cerebral damage after stroke due to anti-inflammatory effects.

Authors:  Bing-Jun Zhang; Xue-Jiao Men; Zheng-Qi Lu; Hai-Yan Li; Wei Qiu; Xue-Qiang Hu
Journal:  Chin Med J (Engl)       Date:  2013-06       Impact factor: 2.628

10.  Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats.

Authors:  Mahasweta Das; Christopher C Leonardo; Saniya Rangooni; Keith R Pennypacker; Subhra Mohapatra; Shyam S Mohapatra
Journal:  J Neuroinflammation       Date:  2011-10-31       Impact factor: 8.322

View more
  23 in total

1.  Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.

Authors:  Farhaan S Vahidy; Kaushik N Parsha; Mohammad H Rahbar; MinJae Lee; Thanh-Tung Bui; Claude Nguyen; Andrew D Barreto; Arvind B Bambhroliya; Preeti Sahota; Bing Yang; Jaroslaw Aronowski; Sean I Savitz
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

Review 2.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

Review 3.  Developing Cellular Therapies for Stroke.

Authors:  Sean I Savitz
Journal:  Stroke       Date:  2015-06-04       Impact factor: 7.914

4.  Experimental ischemic stroke induces long-term T cell activation in the brain.

Authors:  Luokun Xie; Wenjun Li; Jessica Hersh; Ran Liu; Shao-Hua Yang
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-10       Impact factor: 6.200

Review 5.  Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?

Authors:  Nikunj Satani; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 6.  Sex differences in the immune response to experimental stroke: Implications for translational research.

Authors:  Abby L Dotson; Halina Offner
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 7.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

8.  Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.

Authors:  Liu Yang; Ying Kong; Honglei Ren; Minshu Li; Chang-Juan Wei; Elaine Shi; Wei-Na Jin; Junwei Hao; Arthur A Vandenbark; Halina Offner
Journal:  Neurochem Int       Date:  2016-11-21       Impact factor: 3.921

Review 9.  Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Authors:  Gil Benedek; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Neurochem Int       Date:  2016-10-31       Impact factor: 3.921

10.  Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases.

Authors:  Michael Chopp; Zheng Gang Zhang
Journal:  Expert Opin Emerg Drugs       Date:  2015-07-01       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.